Sodium-Lactate and Traumatic Brain Injury
Study Details
Study Description
Brief Summary
The purpose of this study is to compare the effect of bolus of either sodium-lactate or mannitol on the evolution of intracranial pressure (ICP) during intracranial hypertensive episodes (IHE)
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2/Phase 3 |
Detailed Description
Osmotherapy with mannitol remains the first treatment currently recommended to treat intracranial hypertension in severe head injury.However, this treatment in not always efficient and is associated with side-effects and a transitory action. Hypertonic sodium-lactate, by its osmotic and energetic properties could be superior to mannitol to decrease ICP. Study objectives : to compare the effect of mannitol and sodium-lactate on ICP at the fourth hour after the start of infusion during IHE in severe traumatic brain injury (TBI) (main endpoint) ; to compare the percentage of successfully treated episodes between both treatments and to compare the neurological status after one year of evolution (glasgow outcome score)(secondary endpoints)
Patients inclusion : adult severe TBI (glasgow coma score < 9) < 66 yrs Exclusion criteria :
polytrauma, bilateral fixed dilated pupils, motor score < 4, neurosurgery, prolonged episode of hypoxia or arterial hypotension, 34 patients included from november 2003 to november 2004 and randomized into two groups : MAN group receiving mannitol 20% 100 ml in 15 min (17 patients, 36 episodes of IHE treated) and LAC group receiving semimolar sodium-lactate 100 ml in 15 min (17 patients, 37 episodes of IHE treated). For ethical reasons a rescue treatment in a crossover fashion was performed for each episode of IHE when the randomized treatment failed.
Follow-up : one year after the TBI. Study end : november 30, 2005
Study Design
Outcome Measures
Primary Outcome Measures
- Efficiency to decrease ICP during IHE episodes []
Secondary Outcome Measures
- Number of successful treatment, neurological status (Glasgow outcome score) after one year of evolution []
Eligibility Criteria
Criteria
Inclusion Criteria:
-
age between 18 and 65 years
-
severe traumatic brain injury
-
prehospital glasgow coma scale < 9
-
rapid neurological worsening before admission
Exclusion Criteria:
-
neurosurgical intervention
-
polytrauma
-
bilatéral fixed dilated pupils
-
motorscore < 4
-
prolonged episode of hypoxia or arterial hypotension
-
abundant rinorrhea
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | CHU de Nice | Nice | Alpes Maritimes | France | 06006 |
Sponsors and Collaborators
- Institut d'Anesthesiologie des Alpes Maritimes
- Institut National de la Santé Et de la Recherche Médicale, France
- PT Kalbe Farma TBK
Investigators
- Study Director: Carole R ICHAI, MD-PhD,
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CHUN-LM-0001